Sign in

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

e-ISSN 1735-3408
p-ISSN 1735-143X
Authors GuideSubmit manuscript
Citation data

OpenCitations

Works that cite this article, indexed by OpenCitations.

32 resultsUpdated October 20, 2026
← Back to article
1

A Review Potential Radioprotective Mechanism of Molecular Hydrogen via Regulation of Cellular Signaling Pathways

RADINKA JOURNAL OF HEALTH SCIENCE 3(2) (2025)

MD SADIKUJ JAMAN

2

Progress in research on association between cell signal transduction pathways and hepatocellular carcinoma

World Chinese Journal of Digestology 27(21) (2019)

Chun Chen; Zhe Yang; Zan-Song Huang

3

Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells

Cellular Signalling 26(5) (2014)

Dali Zhao; Bo Zhai; Changjun He; Gang Tan; Xian Jiang; Shangha Pan; Xuesong Dong; Zheng Wei; Lixin Ma; Haiquan Qiao; Hongchi Jiang; Xueying Sun

4

Marsdenia tenacissima Extract Induces Autophagy and Apoptosis of Hepatocellular Cells via MIF/mToR Signaling

Evidence-Based Complementary and Alternative Medicine 2022 (2022)

Shuai Lin; Qianwen Sheng; Xiaobin Ma; Shanli Li; Peng Xu; Cong Dai; Meng Wang; Huafeng Kang; Zhijun Dai

5

Evolving Systemic Therapy in Hepatocellular Carcinoma: Current Management and Opportunities for Integration With Radiotherapy

Seminars in Radiation Oncology 28(4) (2018)

Florence K. Keane; Theodore S. Hong; Andrew X. Zhu

6

miR-183-5p Promotes HCC Migration/Invasion via Increasing Aerobic Glycolysis

OncoTargets and Therapy Volume 14 (2021)

Yaqian Niu; Fang Liu; Xiuyue Wang; Yuling Chang; Yanmei Song; Huiyuan Chu; Shisan Bao; Che Chen

7

Precise Immunodetection of PTEN Protein in Human Neoplasia

Cold Spring Harbor Perspectives in Medicine 9(12) (2019)

Rafael Pulido; Janire Mingo; Ayman Gaafar; Caroline E. Nunes-Xavier; Sandra Luna; Leire Torices; Javier C. Angulo; José I. López

8

Relationship between EGFR expression and subcellular localization with cancer development and clinical outcome

Oncotarget 10(20) (2019)

Ge Yan; Mohamed E.M. Saeed; Sebastian Foersch; Jose Schneider; Wilfried Roth; Thomas Efferth

9

<p>Expression and Clinical Significance of ERCC1 and XPF in Human Hepatocellular Carcinoma</p>

OncoTargets and Therapy Volume 13 (2020)

Xiaoli Liao; Yongqiang Li; Hualan Li; Wenfeng Huang; Hongxue Wang; Weimin Xie

10

Prognostic and Predictive Biomarkers: Tools in Personalized Oncology

Molecular Diagnosis & Therapy 18(3) (2014)

Ewelina Nalejska; Ewa Mączyńska; Marzena Anna Lewandowska

11

Genetic alterations in hepatocellular carcinoma: An update

World Journal of Gastroenterology 22(41) (2016)

Zhao-Shan Niu; Xiao-Jun Niu; Wen-Hong Wang

12

Anti-tumor effects of NVP-BKM120 alone or in combination with MEK162 in biliary tract cancer

Cancer Letters 411 (2017)

Ling Jin; Mei-hua Jin; Ah-Rong Nam; Ji-Eun Park; Ju-Hee Bang; Do-Youn Oh; Yung-Jue Bang

13

Diagnostic and prognostic values of contrast-enhanced ultrasound in breast cancer: a retrospective study

OncoTargets and Therapy Volume 10 (2017)

Yi-Xuan Zhao; Shuang Liu; Yan-Bing Hu; Yan-Yan Ge; Dong-Mei Lv

14

Different Faces of Hepatocellular Carcinoma as a Health Threat in 21st Century

Hepatitis Monthly 13(2) (2013)

Behzad Yeganeh; Mohammad Hashemi; Fredrick J. de Serres; Marek J. Los; Saeid Ghavami

15

Small Molecule Inhibitors for Hepatocellular Carcinoma: Advances and Challenges

Molecules 27(17) (2022)

Monica A. Kamal; Yasmine M. Mandour; Mostafa K. Abd El-Aziz; Ulrike Stein; Hend M. El Tayebi

16

2-Methoxyestradiol synergizes with Erlotinib to suppress hepatocellular carcinoma by disrupting the PLAGL2-EGFR-HIF-1/2α signaling loop

Pharmacological Research 169 (2021)

Shufang Zheng; Jiaping Ni; Ying Li; Mingying Lu; Yuchen Yao; Haixin Guo; Meng Jiao; Tianle Jin; Haoying Zhang; Ansheng Yuan; Zhuo Wang; Yong Yang; Zhen Chen; Hongxi Wu; Weiwei Hu

17

Expression and significance of the novel tumor-suppressor gene SMG-1 in hepatocellular carcinoma

Oncology Reports 31(6) (2014)

LI-LI HAN; HAO-CHENG NAN; TAO TIAN; HUI GUO; TING-HUA HU; WEN-JUAN WANG; JIE-QUN MA; LI-LI JIANG; QIAN-QIAN GUO; CHENG-CHENG YANG; XIAO-MIN KANG; YING LIU; YUAN GAO; QI-LUN LIU; KE-JUN NAN

18

Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss

Gastrointestinal Cancer: Targets and Therapy (2015)

Autumn McRee; Adam Sendor; Kathryn Hacker; Shufen Chen; Oishee Sen; Derek Chiang; Anna Snavely; Arlin Rogers; Stephanie Montgomery; W. Kimryn Rathmell; Armando L Corona

19

Active radar guides missile to its target: receptor-based targeted treatment of hepatocellular carcinoma by nanoparticulate systems

Tumor Biology 36(1) (2014)

Jing-Jun Yan; Jia-Zhi Liao; Ju-Sheng Lin; Xing-Xing He

20

Is the Expression of p53, c-<italic>erb</italic>-B2 and Ki-67 Influence the Prognosis of the Non-muscle Invasive Urothelial Bladder Cancer?

The Korean Journal of Urological Oncology 14(2) (2016)

Seok Hyun Kang; Hyun Jin Jung; Eun Kyoung Yang; Jae Shin Park; Hoon Kyu Oh; Duk Yoon Kim

21

Genomic biomarkers to guide precision radiotherapy in prostate cancer

The Prostate 82(S1) (2022)

Philip Sutera; Matthew P. Deek; Kim Van der Eecken; Alexander W. Wyatt; Amar U. Kishan; Jason K. Molitoris; Matthew J. Ferris; M. Minhaj Siddiqui; Zaker Rana; Mark V. Mishra; Young Kwok; Elai Davicioni; Daniel E. Spratt; Piet Ost; Felix Y. Feng; Phuoc T. Tran

22

Ecto‐5′‐nucleotidase (CD73) is a potential target of hepatocellular carcinoma

Journal of Cellular Physiology 234(7) (2018)

Shalaimaiti Shali; Jiangang Yu; Xin Zhang; Xue Wang; Youping Jin; Minsheng Su; Xiaohong Liao; Jerry Yu; Xiuling Zhi; Ping Zhou

23

EGFR and SYNE2 are associated with p21 expression and SYNE2 variants predict post-operative clinical outcomes in HBV-related hepatocellular carcinoma

Scientific Reports 6(1) (2016)

Chuangye Han; Xiwen Liao; Wei Qin; Long Yu; Xiaoguang Liu; Gang Chen; Zhengtao Liu; Sicong Lu; Zhiwei Chen; Hao Su; Guangzhi Zhu; Zili Lu; Zhiming Liu; Xue Qin; Ying Gui; Zengnan Mo; Lequn Li; Tao Peng

24

Contrast-Enhanced Ultrasonography in the Diagnosis and Treatment Modulation of Breast Cancer

Journal of Personalized Medicine 11(2) (2021)

Ioana Boca (Bene); Sorin M. Dudea; Anca I. Ciurea

25

Growth Regulation in Hepatobiliary Cancer: Regulators of the Cell Division Cycle

Tumors and Tumor-Like Lesions of the Hepatobiliary Tract (2016)

Arthur Zimmermann

26

Growth Regulation in Hepatobiliary Cancer: Regulators of the Cell Division Cycle

Tumors and Tumor-Like Lesions of the Hepatobiliary Tract (2016)

Arthur Zimmermann

27

Roles of XRCC1 / XPD / ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization

Genetic Testing and Molecular Biomarkers 20(4) (2016)

Xu-Cai Wang; Fan Wang; Qing-Qing Quan

28

A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma

Oncology 94(6) (2018)

Melanie B. Thomas; Elizabeth Garrett-Mayer; Munazza Anis; Kate Anderton; Tricia Bentz; Andie Edwards; Alan Brisendine; Geoffrey Weiss; Abby B. Siegel; Johanna Bendell; Ari Baron; Vinay Duddalwar; Anthony El-Khoueiry

29

Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine

Genomics, Proteomics & Bioinformatics 15(4) (2017)

Hala Fawzy Mohamed Kamel; Hiba Saeed A. Bagader Al-Amodi

30

SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma

Journal of Clinical Oncology 33(6) (2015)

Andrew X. Zhu; Olivier Rosmorduc; T.R. Jeffry Evans; Paul J. Ross; Armando Santoro; Flair Jose Carrilho; Jordi Bruix; Shukui Qin; Paul J. Thuluvath; Josep M. Llovet; Marie-Aude Leberre; Markus Jensen; Gerold Meinhardt; Yoon-Koo Kang